Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Endocrine disruptors may cause early hair loss.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Hair restoration surgery can effectively increase pubic hair density, with patient satisfaction and natural results largely depending on the chosen hair pattern and graft design.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

Cholesterol transport in hair follicles decreases from growth to regression phase.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Myristoleic acid helps hair growth by boosting cell growth and recycling processes in hair follicle cells.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

No definitive link between finasteride and male breast cancer, but further research is needed.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Adrenal disorders can cause lasting brain and behavior issues in children.

Finasteride doesn't affect ovulation in normal women.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.